• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溃疡性结肠炎的肠易激样症状在深度缓解患者和炎症患者中同样常见:一项基于人群的研究[IBSEN 研究]结果。

Irritable Bowel-like Symptoms in Ulcerative Colitis are as Common in Patients in Deep Remission as in Inflammation: Results From a Population-based Study [the IBSEN Study].

机构信息

Østfold Hospital Trust, Department of Gastroenterology, Grålum, Norway.

Department of Gastroenterology, Oslo University Hospital, Oslo, Norway.

出版信息

J Crohns Colitis. 2018 Mar 28;12(4):389-393. doi: 10.1093/ecco-jcc/jjx152.

DOI:10.1093/ecco-jcc/jjx152
PMID:29186372
Abstract

BACKGROUND AND AIMS

An increased prevalence of irritable bowel syndrome [IBS]-like symptoms has been reported in patients with ulcerative colitis [UC]. Whether ongoing inflammation increases the prevalence of such symptoms is unknown. The aims of this study were to determine the prevalence of IBS-like symptoms in a population-based cohort of UC patients 20 years after diagnosis, and to assess the possible association between such symptoms and ongoing inflammation.

METHODS

Patients diagnosed with UC between 1990 and 1994, in a geographically well-defined area, were included in a prospective follow-up study, and IBS symptoms according to Rome III criteria were recorded 20 years after diagnosis. The patients underwent colonoscopy with biopsies and/or the level of faecal calprotectin was analysed.

RESULTS

A total of 260 patients answered the Rome III questionnaire. The overall prevalence of IBS-like symptoms was 27%. In patients who had no signs of inflammation in colonic biopsies [n = 96] [deep remission], the prevalence was 29%. No difference in prevalence of IBS-like symptoms was found between patients with ongoing inflammation and patients in deep remission.

CONCLUSIONS

IBS-like symptoms in UC patients are frequent after 20 years of disease. Deep remission did not change the frequency of IBS-like symptoms.

摘要

背景和目的

溃疡性结肠炎[UC]患者中报告有较高的肠易激综合征[IBS]样症状的患病率。目前尚不清楚持续的炎症是否会增加此类症状的患病率。本研究的目的是确定诊断为 UC 20 年后的患者中 IBS 样症状的患病率,并评估此类症状与持续炎症之间的可能关联。

方法

在地理上定义明确的区域中,于 1990 年至 1994 年间诊断为 UC 的患者被纳入前瞻性随访研究,根据罗马 III 标准记录诊断后 20 年的 IBS 症状。对患者进行结肠镜检查和/或粪便钙卫蛋白水平分析。

结果

共有 260 名患者回答了罗马 III 问卷。IBS 样症状的总体患病率为 27%。在无结肠活检炎症迹象的患者[n=96] [深度缓解]中,患病率为 29%。在有持续炎症的患者和深度缓解的患者之间,IBS 样症状的患病率没有差异。

结论

UC 患者在患病 20 年后 IBS 样症状较为常见。深度缓解并未改变 IBS 样症状的频率。

相似文献

1
Irritable Bowel-like Symptoms in Ulcerative Colitis are as Common in Patients in Deep Remission as in Inflammation: Results From a Population-based Study [the IBSEN Study].溃疡性结肠炎的肠易激样症状在深度缓解患者和炎症患者中同样常见:一项基于人群的研究[IBSEN 研究]结果。
J Crohns Colitis. 2018 Mar 28;12(4):389-393. doi: 10.1093/ecco-jcc/jjx152.
2
Patients with longstanding ulcerative colitis in remission do not have more irritable bowel syndrome-like symptoms than controls.处于缓解期的长期溃疡性结肠炎患者并不比对照组有更多肠易激综合征样症状。
BMC Gastroenterol. 2016 Nov 24;16(1):139. doi: 10.1186/s12876-016-0553-x.
3
Characterization of IBS-like symptoms in patients with ulcerative colitis in clinical remission.溃疡性结肠炎临床缓解患者的 IBS 样症状特征。
Neurogastroenterol Motil. 2013 Sep;25(9):756-e578. doi: 10.1111/nmo.12163. Epub 2013 Jun 4.
4
Irritable Bowel Syndrome-Like Symptoms in Ulcerative Colitis Patients in Clinical Remission: Association with Residual Colonic Inflammation.溃疡性结肠炎临床缓解患者的肠易激综合征样症状:与残留结肠炎症的关系。
Digestion. 2019;99(1):46-51. doi: 10.1159/000494412. Epub 2018 Dec 14.
5
Prevalence of irritable bowel syndrome-like symptoms in ulcerative colitis patients with clinical and endoscopic evidence of remission: prospective multicenter study.具有临床及内镜缓解证据的溃疡性结肠炎患者中肠易激综合征样症状的患病率:前瞻性多中心研究
Scand J Gastroenterol. 2014 Jun;49(6):674-80. doi: 10.3109/00365521.2014.898084. Epub 2014 Mar 20.
6
The severity of inflammation at onset of ulcerative colitis is not associated with IBS-like symptoms during clinical remission.溃疡性结肠炎发病时的炎症严重程度与临床缓解期的肠易激综合征样症状无关。
J Crohns Colitis. 2015 Sep;9(9):776-83. doi: 10.1093/ecco-jcc/jjv107. Epub 2015 Jun 15.
7
Prevalence of functional dyspepsia-like symptoms in ulcerative colitis patients in clinical remission and overlap with irritable bowel syndrome-like symptoms.溃疡性结肠炎临床缓解患者功能性消化不良样症状的发生率及与肠易激综合征样症状的重叠。
Scand J Gastroenterol. 2020 May;55(5):560-564. doi: 10.1080/00365521.2020.1761998. Epub 2020 May 15.
8
The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity.儿童炎症性肠病中肠易激综合征样症状的流行情况,及其与疾病活动的生化标志物的关系。
Aliment Pharmacol Ther. 2016 Jul;44(2):181-8. doi: 10.1111/apt.13636. Epub 2016 Apr 25.
9
The prevalence of irritable bowel syndrome-type symptoms in inflammatory bowel disease patients in remission.炎症性肠病缓解期患者中肠易激综合征型症状的患病率。
Eur J Gastroenterol Hepatol. 2017 Sep;29(9):1086-1090. doi: 10.1097/MEG.0000000000000921.
10
Presence of Irritable Bowel Syndrome Symptoms in Quiescent Inflammatory Bowel Disease Is Associated with High Rate of Anxiety and Depression.肠易激综合征症状在炎症性肠病缓解期的存在与焦虑和抑郁的高发生率相关。
Dig Dis Sci. 2019 Jul;64(7):1923-1928. doi: 10.1007/s10620-019-05488-8. Epub 2019 Feb 6.

引用本文的文献

1
Irritable Bowel Syndrome in Inflammatory Bowel Disease Patients: Prevalence, Etiology, and Treatment.炎症性肠病患者的肠易激综合征:患病率、病因及治疗
Gastroenterol Hepatol (N Y). 2025 Jul;21(7):415-423.
2
Irritable Bowel Syndrome-like Symptoms in Patients With Ulcerative Colitis in Remission as Compared to Irritable Bowel Syndrome: Symptom Severity and Inflammatory Markers.溃疡性结肠炎缓解期患者与肠易激综合征患者的肠易激综合征样症状:症状严重程度及炎症标志物
J Neurogastroenterol Motil. 2025 Jul 30;31(3):313-320. doi: 10.5056/jnm24010. Epub 2025 Apr 28.
3
Unveiling the efficacy of paroxetine and gabapentin in ulcerative colitis patients in remission with co-existing IBS-like symptoms: a single-blinded randomized clinical trial.
揭示帕罗西汀和加巴喷丁对伴有肠易激综合征样症状的缓解期溃疡性结肠炎患者的疗效:一项单盲随机临床试验。
Front Med (Lausanne). 2024 Nov 20;11:1468885. doi: 10.3389/fmed.2024.1468885. eCollection 2024.
4
Why Symptoms Linger in Quiescent Crohn's Disease: Investigating the Impact of Sulfidogenic Microbes and Sulfur Metabolic Pathways.为何症状在静止期克罗恩病中持续存在:探究产硫化氢微生物和硫代谢途径的影响
Inflamm Bowel Dis. 2025 Mar 3;31(3):763-776. doi: 10.1093/ibd/izae238.
5
Multisample lipidomic profiles of irritable bowel syndrome and irritable bowel syndrome-like symptoms in patients with inflammatory bowel disease: new insight into the recognition of the same symptoms in different diseases.炎症性肠病患者肠易激综合征和肠易激综合征样症状的多样本脂质组学特征:不同疾病中相同症状识别的新见解。
J Gastroenterol. 2024 Nov;59(11):1000-1010. doi: 10.1007/s00535-024-02148-1. Epub 2024 Sep 10.
6
The Microbiome in Quiescent Crohn's Disease With Persistent Symptoms Show Disruptions in Microbial Sulfur and Tryptophan Pathways.有持续症状的静止期克罗恩病患者的微生物群显示微生物硫和色氨酸途径存在破坏。
Gastro Hep Adv. 2023 Nov 23;3(2):167-177. doi: 10.1016/j.gastha.2023.11.005. eCollection 2024.
7
A pilot randomized controlled trial investigating the effects of an anti-inflammatory dietary pattern on disease activity, symptoms and microbiota profile in adults with inflammatory bowel disease.一项探索抗炎饮食模式对炎症性肠病成年患者疾病活动度、症状及微生物群特征影响的前瞻性随机对照试验。
Eur J Clin Nutr. 2024 Dec;78(12):1072-1081. doi: 10.1038/s41430-024-01487-9. Epub 2024 Aug 10.
8
Acceptance and commitment therapy for the treatment of irritable bowel syndrome and inflammatory bowel disease: a narrative review.接受与承诺疗法治疗肠易激综合征和炎症性肠病:一项叙述性综述
Transl Gastroenterol Hepatol. 2024 Jun 24;9:43. doi: 10.21037/tgh-24-10. eCollection 2024.
9
Residual Disease Burden Among European Patients With Inflammatory Bowel Disease: A Real-World Survey.欧洲炎症性肠病患者的残余疾病负担:一项真实世界调查
Inflamm Bowel Dis. 2025 Feb 6;31(2):411-424. doi: 10.1093/ibd/izae119.
10
Predictors of irritable bowel syndrome-like symptoms in quiescent inflammatory bowel disease.缓解期炎症性肠病中肠易激综合征样症状的预测因素。
Neurogastroenterol Motil. 2024 Jun;36(6):e14809. doi: 10.1111/nmo.14809. Epub 2024 Apr 23.